Mirae Asset Global Investments’s Caribou Biosciences CRBU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.81K Sell
4,436
-439
-9% -$868 ﹤0.01% 1594
2026
Q1
$9.26K Buy
4,875
+333
+7% +$572 ﹤0.01% 1504
2025
Q4
$7.22K Buy
+4,542
New +$9.53K ﹤0.01% 1619
2024
Q4
Sell
-3,268
Closed -$6.47K 1607
2024
Q3
$6.47K Buy
3,268
+572
+21% +$1.17K ﹤0.01% 1514
2024
Q2
$4.53K Sell
2,696
-227,496
-99% -$727K ﹤0.01% 1493
2024
Q1
$1.1M Buy
230,192
+56,586
+33% +$349K ﹤0.01% 1486
2023
Q4
$995K Sell
173,606
-118,285
-41% -$585K ﹤0.01% 1625
2023
Q3
$1.4M Buy
291,891
+40,222
+16% +$250K ﹤0.01% 1358
2023
Q2
$1.07M Buy
251,669
+28,432
+13% +$128K ﹤0.01% 1527
2023
Q1
$1.19M Buy
223,237
+10,586
+5% +$65.9K ﹤0.01% 1454
2022
Q4
$1.34M Sell
212,651
-38,979
-15% -$347K ﹤0.01% 1341
2022
Q3
$2.65M Buy
251,630
+32,965
+15% +$307K 0.01% 1027
2022
Q2
$1.19M Buy
218,665
+67,500
+45% +$516K ﹤0.01% 1327
2022
Q1
$1.39M Sell
151,165
-27,748
-16% -$292K ﹤0.01% 1251
2021
Q4
$2.7M Buy
+178,913
New +$3.48M 0.01% 1048

Other funds holding CRBU

Mirae Asset Global Investments's CRBU Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Caribou Biosciences (CRBU) stake by 9% in Q2 2026, selling an estimated $868 and leaving 4,436 shares worth $7.81K. The position accounts for ﹤0.01% of the portfolio, ranked #1594.

Mirae Asset Global Investments first reported a position in CRBU in Q4 2021 and has held it in 15 quarters since. The position peaked at $2.7M in Q4 2021. 45 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Mirae Asset Global Investments held 4,436 shares of Caribou Biosciences worth $7.81K as of Q2 2026.
  • Mirae Asset Global Investments sold 439 Caribou Biosciences shares in Q2 2026, an estimated $868.
  • Caribou Biosciences made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1594 holding.
  • Mirae Asset Global Investments first reported a position in Caribou Biosciences in Q4 2021 and has held it in 15 quarters since.
  • Mirae Asset Global Investments's Caribou Biosciences position peaked at $2.7M in Q4 2021.
  • 45 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.